Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
42
MDT Quote, Financials, Valuation and Earnings
Last price:
$86.64
Seasonality move
:
4.08%
Day range:
$85.21 - $86.97
52-week range:
$79.55 - $106.33
Dividend yield:
3.26%
P/E ratio:
24.35x
P/S ratio:
3.17x
P/B ratio:
2.29x
Volume:
4.4M
Avg. volume:
8M
1-year change:
-2.51%
Market cap:
$112B
Revenue:
$33.5B
EPS (TTM):
$3.58
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
MDT
Medtronic Plc
|
$9.6B | $1.54 | 8.09% | 88.16% | $110.60 |
|
ABT
Abbott Laboratories
|
$11B | $1.15 | 13.48% | 31.15% | $132.28 |
|
BSX
Boston Scientific Corp.
|
$5.6B | $0.86 | 9.79% | 62% | $100.81 |
|
CNMD
CONMED Corp.
|
$340.6M | $1.09 | -2.76% | 322.31% | $44.20 |
|
ISRG
Intuitive Surgical, Inc.
|
$2.8B | $2.48 | 16.31% | 10.98% | $605.08 |
|
SYK
Stryker Corp.
|
$6.6B | $3.46 | 8.32% | 77.05% | $425.08 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
MDT
Medtronic Plc
|
$86.63 | $110.60 | $112B | 24.35x | $0.71 | 3.26% | 3.17x |
|
ABT
Abbott Laboratories
|
$102.87 | $132.28 | $179.6B | 27.68x | $0.63 | 2.32% | 4.06x |
|
BSX
Boston Scientific Corp.
|
$62.82 | $100.81 | $94.5B | 32.82x | $0.00 | 0% | 4.74x |
|
CNMD
CONMED Corp.
|
$34.79 | $44.20 | $1.1B | 22.48x | $0.20 | 2.35% | 0.77x |
|
ISRG
Intuitive Surgical, Inc.
|
$452.07 | $605.08 | $156.3B | 55.87x | $0.00 | 0% | 15.86x |
|
SYK
Stryker Corp.
|
$331.54 | $425.08 | $127.7B | 39.74x | $0.88 | 1.03% | 5.14x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
MDT
Medtronic Plc
|
36.43% | 1.050 | 21.21% | 1.57x |
|
ABT
Abbott Laboratories
|
21.33% | 0.736 | 6.98% | 1.05x |
|
BSX
Boston Scientific Corp.
|
33.07% | 1.671 | 8.45% | 0.94x |
|
CNMD
CONMED Corp.
|
46.21% | 1.725 | 70.58% | 0.94x |
|
ISRG
Intuitive Surgical, Inc.
|
0.95% | 0.639 | 0.08% | 3.73x |
|
SYK
Stryker Corp.
|
42.19% | 0.974 | 12.42% | 1.07x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
MDT
Medtronic Plc
|
$5.4B | $1.7B | 6.01% | 9.51% | 19.09% | $2.3B |
|
ABT
Abbott Laboratories
|
$6.1B | $2.4B | 10.13% | 12.91% | 20.68% | $2.6B |
|
BSX
Boston Scientific Corp.
|
$3.6B | $1.2B | 8.3% | 12.55% | 22.93% | $1B |
|
CNMD
CONMED Corp.
|
$213.3M | $66.9M | 2.49% | 4.72% | 17.91% | $41.2M |
|
ISRG
Intuitive Surgical, Inc.
|
$1.9B | $864.3M | 16.53% | 16.59% | 30.16% | $730M |
|
SYK
Stryker Corp.
|
$4.5B | $2B | 8.59% | 15.17% | 27.74% | $1.9B |
Medtronic Plc vs. Competitors
-
Which has Higher Returns MDT or ABT?
Abbott Laboratories has a net margin of 12.75% compared to Medtronic Plc's net margin of 15.71%. Medtronic Plc's return on equity of 9.51% beat Abbott Laboratories's return on equity of 12.91%.
Company Gross Margin Earnings Per Share Invested Capital MDTMedtronic Plc59.81% $0.89 $77.3B ABTAbbott Laboratories53.5% $1.03 $66.9B -
What do Analysts Say About MDT or ABT?
Medtronic Plc has a consensus price target of $110.60, signalling upside risk potential of 27.67%. On the other hand Abbott Laboratories has an analysts' consensus of $132.28 which suggests that it could grow by 28.59%. Given that Abbott Laboratories has higher upside potential than Medtronic Plc, analysts believe Abbott Laboratories is more attractive than Medtronic Plc.
Company Buy Ratings Hold Ratings Sell Ratings MDTMedtronic Plc14 12 0 ABTAbbott Laboratories16 7 0 -
Is MDT or ABT More Risky?
Medtronic Plc has a beta of 0.747, which suggesting that the stock is 25.32% less volatile than S&P 500. In comparison Abbott Laboratories has a beta of 0.787, suggesting its less volatile than the S&P 500 by 21.251%.
-
Which is a Better Dividend Stock MDT or ABT?
Medtronic Plc has a quarterly dividend of $0.71 per share corresponding to a yield of 3.26%. Abbott Laboratories offers a yield of 2.32% to investors and pays a quarterly dividend of $0.63 per share. Medtronic Plc pays 77.47% of its earnings as a dividend. Abbott Laboratories pays out 64.54% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios MDT or ABT?
Medtronic Plc quarterly revenues are $9B, which are smaller than Abbott Laboratories quarterly revenues of $11.5B. Medtronic Plc's net income of $1.2B is lower than Abbott Laboratories's net income of $1.8B. Notably, Medtronic Plc's price-to-earnings ratio is 24.35x while Abbott Laboratories's PE ratio is 27.68x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medtronic Plc is 3.17x versus 4.06x for Abbott Laboratories. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MDTMedtronic Plc3.17x 24.35x $9B $1.2B ABTAbbott Laboratories4.06x 27.68x $11.5B $1.8B
-
Which has Higher Returns MDT or BSX?
Boston Scientific Corp. has a net margin of 12.75% compared to Medtronic Plc's net margin of 12.68%. Medtronic Plc's return on equity of 9.51% beat Boston Scientific Corp.'s return on equity of 12.55%.
Company Gross Margin Earnings Per Share Invested Capital MDTMedtronic Plc59.81% $0.89 $77.3B BSXBoston Scientific Corp.68.5% $0.45 $36.4B -
What do Analysts Say About MDT or BSX?
Medtronic Plc has a consensus price target of $110.60, signalling upside risk potential of 27.67%. On the other hand Boston Scientific Corp. has an analysts' consensus of $100.81 which suggests that it could grow by 60.48%. Given that Boston Scientific Corp. has higher upside potential than Medtronic Plc, analysts believe Boston Scientific Corp. is more attractive than Medtronic Plc.
Company Buy Ratings Hold Ratings Sell Ratings MDTMedtronic Plc14 12 0 BSXBoston Scientific Corp.24 0 0 -
Is MDT or BSX More Risky?
Medtronic Plc has a beta of 0.747, which suggesting that the stock is 25.32% less volatile than S&P 500. In comparison Boston Scientific Corp. has a beta of 0.781, suggesting its less volatile than the S&P 500 by 21.926%.
-
Which is a Better Dividend Stock MDT or BSX?
Medtronic Plc has a quarterly dividend of $0.71 per share corresponding to a yield of 3.26%. Boston Scientific Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medtronic Plc pays 77.47% of its earnings as a dividend. Boston Scientific Corp. pays out -- of its earnings as a dividend. Medtronic Plc's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios MDT or BSX?
Medtronic Plc quarterly revenues are $9B, which are larger than Boston Scientific Corp. quarterly revenues of $5.3B. Medtronic Plc's net income of $1.2B is higher than Boston Scientific Corp.'s net income of $670M. Notably, Medtronic Plc's price-to-earnings ratio is 24.35x while Boston Scientific Corp.'s PE ratio is 32.82x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medtronic Plc is 3.17x versus 4.74x for Boston Scientific Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MDTMedtronic Plc3.17x 24.35x $9B $1.2B BSXBoston Scientific Corp.4.74x 32.82x $5.3B $670M
-
Which has Higher Returns MDT or CNMD?
CONMED Corp. has a net margin of 12.75% compared to Medtronic Plc's net margin of 4.48%. Medtronic Plc's return on equity of 9.51% beat CONMED Corp.'s return on equity of 4.72%.
Company Gross Margin Earnings Per Share Invested Capital MDTMedtronic Plc59.81% $0.89 $77.3B CNMDCONMED Corp.57.12% $0.54 $1.9B -
What do Analysts Say About MDT or CNMD?
Medtronic Plc has a consensus price target of $110.60, signalling upside risk potential of 27.67%. On the other hand CONMED Corp. has an analysts' consensus of $44.20 which suggests that it could grow by 27.05%. Given that Medtronic Plc has higher upside potential than CONMED Corp., analysts believe Medtronic Plc is more attractive than CONMED Corp..
Company Buy Ratings Hold Ratings Sell Ratings MDTMedtronic Plc14 12 0 CNMDCONMED Corp.0 6 0 -
Is MDT or CNMD More Risky?
Medtronic Plc has a beta of 0.747, which suggesting that the stock is 25.32% less volatile than S&P 500. In comparison CONMED Corp. has a beta of 0.986, suggesting its less volatile than the S&P 500 by 1.399%.
-
Which is a Better Dividend Stock MDT or CNMD?
Medtronic Plc has a quarterly dividend of $0.71 per share corresponding to a yield of 3.26%. CONMED Corp. offers a yield of 2.35% to investors and pays a quarterly dividend of $0.20 per share. Medtronic Plc pays 77.47% of its earnings as a dividend. CONMED Corp. pays out 18.82% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios MDT or CNMD?
Medtronic Plc quarterly revenues are $9B, which are larger than CONMED Corp. quarterly revenues of $373.5M. Medtronic Plc's net income of $1.2B is higher than CONMED Corp.'s net income of $16.7M. Notably, Medtronic Plc's price-to-earnings ratio is 24.35x while CONMED Corp.'s PE ratio is 22.48x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medtronic Plc is 3.17x versus 0.77x for CONMED Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MDTMedtronic Plc3.17x 24.35x $9B $1.2B CNMDCONMED Corp.0.77x 22.48x $373.5M $16.7M
-
Which has Higher Returns MDT or ISRG?
Intuitive Surgical, Inc. has a net margin of 12.75% compared to Medtronic Plc's net margin of 27.89%. Medtronic Plc's return on equity of 9.51% beat Intuitive Surgical, Inc.'s return on equity of 16.59%.
Company Gross Margin Earnings Per Share Invested Capital MDTMedtronic Plc59.81% $0.89 $77.3B ISRGIntuitive Surgical, Inc.66.41% $2.21 $18.1B -
What do Analysts Say About MDT or ISRG?
Medtronic Plc has a consensus price target of $110.60, signalling upside risk potential of 27.67%. On the other hand Intuitive Surgical, Inc. has an analysts' consensus of $605.08 which suggests that it could grow by 33.85%. Given that Intuitive Surgical, Inc. has higher upside potential than Medtronic Plc, analysts believe Intuitive Surgical, Inc. is more attractive than Medtronic Plc.
Company Buy Ratings Hold Ratings Sell Ratings MDTMedtronic Plc14 12 0 ISRGIntuitive Surgical, Inc.17 9 1 -
Is MDT or ISRG More Risky?
Medtronic Plc has a beta of 0.747, which suggesting that the stock is 25.32% less volatile than S&P 500. In comparison Intuitive Surgical, Inc. has a beta of 1.677, suggesting its more volatile than the S&P 500 by 67.7%.
-
Which is a Better Dividend Stock MDT or ISRG?
Medtronic Plc has a quarterly dividend of $0.71 per share corresponding to a yield of 3.26%. Intuitive Surgical, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medtronic Plc pays 77.47% of its earnings as a dividend. Intuitive Surgical, Inc. pays out -- of its earnings as a dividend. Medtronic Plc's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios MDT or ISRG?
Medtronic Plc quarterly revenues are $9B, which are larger than Intuitive Surgical, Inc. quarterly revenues of $2.9B. Medtronic Plc's net income of $1.2B is higher than Intuitive Surgical, Inc.'s net income of $799.5M. Notably, Medtronic Plc's price-to-earnings ratio is 24.35x while Intuitive Surgical, Inc.'s PE ratio is 55.87x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medtronic Plc is 3.17x versus 15.86x for Intuitive Surgical, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MDTMedtronic Plc3.17x 24.35x $9B $1.2B ISRGIntuitive Surgical, Inc.15.86x 55.87x $2.9B $799.5M
-
Which has Higher Returns MDT or SYK?
Stryker Corp. has a net margin of 12.75% compared to Medtronic Plc's net margin of 11.84%. Medtronic Plc's return on equity of 9.51% beat Stryker Corp.'s return on equity of 15.17%.
Company Gross Margin Earnings Per Share Invested Capital MDTMedtronic Plc59.81% $0.89 $77.3B SYKStryker Corp.62.81% $2.20 $38.8B -
What do Analysts Say About MDT or SYK?
Medtronic Plc has a consensus price target of $110.60, signalling upside risk potential of 27.67%. On the other hand Stryker Corp. has an analysts' consensus of $425.08 which suggests that it could grow by 28.21%. Given that Stryker Corp. has higher upside potential than Medtronic Plc, analysts believe Stryker Corp. is more attractive than Medtronic Plc.
Company Buy Ratings Hold Ratings Sell Ratings MDTMedtronic Plc14 12 0 SYKStryker Corp.13 8 0 -
Is MDT or SYK More Risky?
Medtronic Plc has a beta of 0.747, which suggesting that the stock is 25.32% less volatile than S&P 500. In comparison Stryker Corp. has a beta of 0.919, suggesting its less volatile than the S&P 500 by 8.094%.
-
Which is a Better Dividend Stock MDT or SYK?
Medtronic Plc has a quarterly dividend of $0.71 per share corresponding to a yield of 3.26%. Stryker Corp. offers a yield of 1.03% to investors and pays a quarterly dividend of $0.88 per share. Medtronic Plc pays 77.47% of its earnings as a dividend. Stryker Corp. pays out 40.48% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios MDT or SYK?
Medtronic Plc quarterly revenues are $9B, which are larger than Stryker Corp. quarterly revenues of $7.2B. Medtronic Plc's net income of $1.2B is higher than Stryker Corp.'s net income of $849M. Notably, Medtronic Plc's price-to-earnings ratio is 24.35x while Stryker Corp.'s PE ratio is 39.74x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medtronic Plc is 3.17x versus 5.14x for Stryker Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MDTMedtronic Plc3.17x 24.35x $9B $1.2B SYKStryker Corp.5.14x 39.74x $7.2B $849M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
46
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 36x
Sell
49
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 27x
Alerts
Buy
51
AAOI alert for Apr 4
Applied Optoelectronics, Inc. [AAOI] is up 20.3% over the past day.
Buy
59
SBAC alert for Apr 4
SBA Communications Corp. [SBAC] is up 18.96% over the past day.
Buy
55
VSAT alert for Apr 4
ViaSat, Inc. [VSAT] is up 18.73% over the past day.
